Kewaunee Scientific Ties VP Compensation to Long-Term Performance Goals

Rhea-AI Filing Summary

Elizabeth D. Phillips, VP of Human Resources at Kewaunee Scientific Corp (KEQU), received a grant of 4,111 Restricted Stock Units (RSUs) on June 25, 2025. The RSU grant is structured in two parts:

• 50% Service-Based RSUs: 2,055.5 units vesting in three equal annual installments starting June 30, 2026, contingent on continued employment
• 50% Performance-Based RSUs: 2,055.5 units subject to three-year performance goals

The RSUs represent the right to receive an equivalent number of common stock shares upon vesting. The grant was made at $0 cost to the executive. Final vesting of performance-based units will depend on achievement of undisclosed performance metrics over the three-year period. This equity award aligns executive compensation with both long-term service and company performance goals.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Phillips Elizabeth D

Role VP - Human Resources

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units FY26	4,111	$0.00	--

Holdings After Transaction: Restricted Stock Units FY26 — 4,111 shares (Direct)

Footnotes (1)

1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The award of restricted stock units shall vest as follows: (a) 50% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning June 30, 2026, subject to the reporting person's continued employment with the Company; and (b) 50% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that will vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phillips Elizabeth D

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NC 28677

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP - Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units FY26	(1)	06/25/2025		A		4,111		(2)	(2)	Common Stock	4,111	$0	4,111	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

2. The award of restricted stock units shall vest as follows: (a) 50% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning June 30, 2026, subject to the reporting person's continued employment with the Company; and (b) 50% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that will vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	06/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many restricted stock units (RSUs) did Elizabeth Phillips receive at KEQU on June 25, 2025?

Elizabeth Phillips, VP of Human Resources at Kewaunee Scientific Corp (KEQU), received 4,111 restricted stock units on June 25, 2025.

What is the vesting schedule for KEQU's restricted stock units granted in June 2025?

The RSUs have a split vesting schedule: 50% are service-based units vesting in three equal annual installments starting June 30, 2026, and 50% are performance-based units vesting over a three-year period subject to achieving performance goals.

Who is Elizabeth Phillips at KEQU and what is her role?

Elizabeth Phillips serves as Vice President of Human Resources at Kewaunee Scientific Corporation (KEQU), as disclosed in the Form 4 filing.

What was the purchase price of the restricted stock units granted to KEQU's VP of HR?

The restricted stock units were granted at $0 cost to Elizabeth Phillips, as indicated in the Form 4 filing under the 'Price of Derivative Security' column.

When will KEQU's 2025 restricted stock units begin vesting?

The service-based portion (50%) of the restricted stock units will begin vesting on June 30, 2026, with subsequent vestings occurring annually over three years, subject to continued employment.